Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome
Authors:
- Diego Real de AsuaDADiego Real de Asua
- Miguel A. MayerMMMiguel A. Mayer
- María del Carmen OrtegaMOMaría del Carmen Ortega
- Jose M. BorrelJBJose M. Borrel
- Teresa de Jesús BermejoTBTeresa de Jesús Bermejo
- Domingo González-LamuñoDomingo González-Lamuño
- Coral MansoCMCoral Manso
- Fernando MoldenhauerFMFernando Moldenhauer
- María Carmona-IraguiMCMaría Carmona-Iragui
- Anke HülsAHAnke Hüls
- Stephanie L. ShermanSSStephanie L. Sherman
- Andre StrydomASAndre Strydom
Open Access
- 23 August 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (16) , 3748
Abstract
Whether the increased risk for coronavirus disease 2019 (COVID-19) hospitalization and death observed in Down syndrome (DS) are disease specific or also occur in individuals with DS and non-COVID-19 pneumonias is unknown. This retrospective cohort study compared COVID-19 cases in persons with DS hospitalized in Spain reported to the Trisomy 21 Research Society COVID-19 survey (n = 86) with admissions for non-COVID-19 pneumonias from a retrospective clinical database of the Spanish Ministry of Health (n = 2832 patients). In-hospital mortality rates were significantly higher for COVID-19 patients (26.7% vs. 9.4%), especially among individuals over 40 and patients with obesity, dementia, and/or epilepsy. The mean length of stay of deceased patients with COVID-19 was significantly shorter than in those with non-COVID-19 pneumonias. The rate of admission to an ICU in patients with DS and COVID-19 (4.3%) was significantly lower than that reported for the general population with COVID-19. Our findings confirm that acute SARS-CoV-2 infection leads to higher mortality than non-COVID-19 pneumonias in individuals with DS, especially among adults over 40 and those with specific comorbidities. However, differences in access to respiratory support might also account for some of the heightened mortality of individuals with DS with COVID-19.Keywords
Funding Information
- Departament d'Universitats, Recerca i Societat de la Informació (2017 SGR 926, 2017 SGR 138)
- Agencia Estatal de Investigación (PID2019-110755RB-I00/AEI / 10.13039/501100011033)
- H2020 Health (grant agreement No 848077)
- Jerome Lejeune Foundation (2002)
- NIH Blueprint for Neuroscience Research (1R01EB 028159-01)
- EU Joint Programme – Neurodegenerative Disease Research (HEROES)
- Instituto de Salud Carlos III (PI19/00634, PT17/0009/0014)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2017 SGR 00519)
This publication has 29 references indexed in Scilit:
- Características de los adultos con síndrome de Down ingresados en los servicios de medicina interna españoles en el periodo 2005-2014Revista Clínica Española, 2020
- Down Syndrome and COVID-19: A Perfect Storm?Cell Reports Medicine, 2020
- Respiratory Syncytial Virus-related Death in Children With Down SyndromeThe Pediatric Infectious Disease Journal, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Down Syndrome and the Risk of Severe RSV Infection: A Meta-analysisPediatrics, 2018
- Variations in dementia diagnosis in England and association with general practice characteristicsPrimary Health Care Research & Development, 2017
- Underdiagnosis of dementia in primary care: Variations in the observed prevalence and comparisons to the expected prevalenceAging & Mental Health, 2011
- Pandemic (H1N1) 2009 Virus and Down Syndrome PatientsEmerging Infectious Diseases, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Down Syndrome: A Novel Risk Factor for Respiratory Syncytial Virus Bronchiolitis— A Prospective Birth-Cohort StudyPediatrics, 2007